All Posts By

Smartkarma Daily Briefs

Daily Brief Consumer: Fosun Tourism, China Tobacco International (HK), Mao Geping Cosmetics, Ginebra San Miguel , TSE Tokyo Price Index TOPIX and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Fosun Tourism (1992.HK) Privatization – The Cancellation Price Is Not Good Enough
  • China Tobacco Intl (6055 HK): A Bullish Expectation
  • ECM Weekly (16th Dec 2024) – LG CNS, Mao Geping, Digico, Kioxia, Vishal Mega, IGI, Sai Life, Quantum
  • Shortlist of High Conviction Philippines Equity Ideas – December 2024
  • The Situation Is Different for REITs that Rely on Capital Increase, Despite the Same Low P/B Issue


Fosun Tourism (1992.HK) Privatization – The Cancellation Price Is Not Good Enough

By Xinyao (Criss) Wang

  • Fosun Tourism has emerged from its difficulties and started an upward trend.If it remains listed, it’s only a matter of time before its share price returns to the IPO price.
  • Temasek was once in talks to buy a minority stake in Club Med from Fosun International for €500 million, based on which reasonable valuation for Fosun Tourism is RMB12.6 billion.
  • Fosun has continued its style- When performance recovery hasn’t been reflected in stock price, it’s the right time to privatize valuable assets at cheap price. A share alternative is expected.

China Tobacco Intl (6055 HK): A Bullish Expectation

By Osbert Tang, CFA

  • Management of China Tobacco International (HK) (6055 HK) is bullish on earnings in the next two years, with tobacco leaf import and cigarette export being the key drivers.
  • Elevated tobacco leaf price is positive to CTI while more re-opening of duty-free shops (currently only 50% of pre-COVID level) will add to revenue momentum.
  • A light gearing of just 2% and potentially more parent asset injection are CTI’s strengths. The company plans to maintain a steady uptrend on absolute DPS annually. 

ECM Weekly (16th Dec 2024) – LG CNS, Mao Geping, Digico, Kioxia, Vishal Mega, IGI, Sai Life, Quantum

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, a number of offerings were live in India, in a bid to beat the year-end lull.
  • On the placements front, there was a large placement for SenseTime Group (20 HK) and a number of smaller deals in India.

Shortlist of High Conviction Philippines Equity Ideas – December 2024

By Sameer Taneja


The Situation Is Different for REITs that Rely on Capital Increase, Despite the Same Low P/B Issue

By Aki Matsumoto

  • Repurchasing investment units, increasing dividends through property sales, and increasing EPS through negative goodwill of M&A seem to be the share price raising measures necessary for capital increase for growth.
  • When increasing capital amid stagnated REIT stock prices, it’s questionable whether the picture that is drawn after capital increase is reasonable in the face of rising required returns by investors.
  • When the profitability of REIT investment companies is in question, it is not surprising that activist investors will focus on management issues, including cost of capital or corporate governance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Telix Pharmaceuticals, Inventurus Knowledge Solutions and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • MV Australia Equal Weight Index Rebalance: One Add & Capping Leads to A$290m Trade
  • [Quiddity Index] MV Australia Equal Weight Dec 24 Rebal Results: Flow Expectations
  • Inventurus Knowledge Solutions IPO: Superior Margins and Growth Warrants a Premium


MV Australia Equal Weight Index Rebalance: One Add & Capping Leads to A$290m Trade

By Brian Freitas


[Quiddity Index] MV Australia Equal Weight Dec 24 Rebal Results: Flow Expectations

By Travis Lundy

  • The MV Australia Equal Weight Index represents the performance of large, liquid companies incorporated in Australia and listed on the ASX.
  • Telix Pharmaceuticals (TLX AU) is an ADD for the December 2024 review, with no other changes to the index.
  • We expect a one-way flow of $US90mm for December 2024, which translates to a turnover of 5.5%.

Inventurus Knowledge Solutions IPO: Superior Margins and Growth Warrants a Premium

By Nicholas Tan

  • Inventurus Knowledge Solutions (IKSINCD IN) is looking to raise up to US$295m in its upcoming India IPO.
  • It is a technology-enabled healthcare solutions provider, assisting physician enterprises in US, Canada and Australia, with a core focus in the US.
  • We have looked at the company’s past performance in our earlier notes. In this note, we discuss the industry growth, conduct a quick peer comparison and discuss the company’s valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: A-H Premium Weekly (Dec 13th):ZOOMLION and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • A-H Premium Weekly (Dec 13th):ZOOMLION, QDP, BeiGene, INNOCARE, TEC, MA STEEL, AIR CHINA
  • HK Short Interest Weekly: Midea, Xpeng, Jd, Meituan, Tracker Fund, HSBC
  • Hong Kong Connect Flows (Dec 13th): Alibaba, CCB, China Mobile, ICBC, Byd Electronic (International)


A-H Premium Weekly (Dec 13th):ZOOMLION, QDP, BeiGene, INNOCARE, TEC, MA STEEL, AIR CHINA

By Ke Yan, CFA, FRM

  • We analyse the changes of A-H premium on 150 stocks over the last week. The average A-H premium was 101.0% as of Dec 13th.
  • The average A-H premium changed by -1.9ppt week-on-week, led by consumer staples, consumer discretionary, industrials and offset by real estate.
  • We highlight weekly changes in A-H premium for ZOOMLION, QDP, BeiGene, INNOCARE, TEC, MA STEEL, AIR CHINA.

HK Short Interest Weekly: Midea, Xpeng, Jd, Meituan, Tracker Fund, HSBC

By Ke Yan, CFA, FRM

  • We analyzed the latest HK SFC report for aggregate short position as of Dec 6th.
  • Top short increases and decreases were tabulated for one week and four week period. 
  • We highlight short changes in Xpeng, Jd, Meituan, Tracker Fund, HSBC.

Hong Kong Connect Flows (Dec 13th): Alibaba, CCB, China Mobile, ICBC, Byd Electronic (International)

By Ke Yan, CFA, FRM

  • We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of December 13th.
  • The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
  • We highlight flows for Alibaba, CCB, China Mobile, ICBC, Byd Electronic (International), Meituan, Wuxi Biologics, Tencent.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): APAC Healthcare Weekly (Dec 15)-Daiichi Sankyo and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • APAC Healthcare Weekly (Dec 15)-Daiichi Sankyo, Eisai, Celltrion, Metropolis Healthcare, CSPC Pharma


APAC Healthcare Weekly (Dec 15)-Daiichi Sankyo, Eisai, Celltrion, Metropolis Healthcare, CSPC Pharma

By Tina Banerjee

  • Daiichi Sankyo is investing $152M for building a new ADC manufacturing facility in Shanghai. Eisai has received approval for Urece in China as a treatment for gout patients with hyperuricemia.
  • Celltrion has announced its largest-ever dividend of KRW750 per share and 1:20 bonus shares. The record date for dividend payment and bonus share is December 31.
  • Metropolis Healthcare is acquiring Core Diagnostics, a prominent player in India’s specialized diagnostics sector for INR2.5B. CSPC Pharmaceutical has granted an exclusive license to Beigene for a clinical-stage drug candidate.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Yoon’s Impeachment Passed: Upcoming Schedule and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Yoon’s Impeachment Passed: Upcoming Schedule, Procedures, and Market Impact
  • HK Connect SOUTHBOUND Flows (To 13 Dec 2024); Politburo Policy Change Bullish, Markets Wary, Buying
  • A/H Premium Tracker (To 13 Dec 2024): Pairwise Intracorrelation and Vol Way Up, Premia Down
  • CPMC (906 HK): Not A Shadow Of Doubt (!) As Pre-Cons Fulfilled
  • MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: One Add, One Delete & Other Changes
  • China Healthcare Weekly (Dec.15) – 10th VBP Results, WuXi Shares Surge, Newjf Will Be Successful
  • Quiddity Leaderboard Hang Seng Internet & IT March 25: 4 Changes Likely, Some Names Have High Impact
  • A Review of Major Equity Indices in Korea in 2024
  • Last Week in Event SPACE: NEC Network, SingPost, Seven & I, CPMC, Exedy
  • Quiddity Leaderboard HSCEI Mar 25: One Change Likely but More Names Lurking Close to the Border


Yoon’s Impeachment Passed: Upcoming Schedule, Procedures, and Market Impact

By Sanghyun Park

  • The impeachment motion against President Yoon passed in the South Korean National Assembly, clearing the two-thirds supermajority, and is now official.
  • For the impeachment to fail, four justices must oppose it—highly unlikely given the current setup. The odds are heavily in favor of the impeachment being upheld.
  • Corporate law reforms, driven by a likely Democratic Party takeover, could fuel value-up momentum and drive the local market, potentially sparking an unexpected rally through the May election.

HK Connect SOUTHBOUND Flows (To 13 Dec 2024); Politburo Policy Change Bullish, Markets Wary, Buying

By Travis Lundy

  • SOUTHBOUND gross trading activity rebounded about 33% this week vs the previous week. Net buying was a little lower but still strong. Market volumes overall in HK rebounded.
  • Alibaba Group Holding (9988 HK) was again the top buy and Tencent (700 HK) and Meituan (3690 HK) the top two sells. Tech is having a mixed outing now.
  • Gross SOUTHBOUND volumes back up this week to levels seen just off the autumn peak. An interesting week as stocks popped Monday, opened high Tuesday, then fell all week.

A/H Premium Tracker (To 13 Dec 2024): Pairwise Intracorrelation and Vol Way Up, Premia Down

By Travis Lundy

  • Mainland share market volumes continue to be better than HK and SOUTHBOUND volumes, but SB volumes rebounded, tech saw limited net buying, BABA was bought but other major tech sold.
  • The first leg of China’s retaliatory acts against US trade measures appeared with export bans on gallium, germanium, antimony, graphite products, etc. These will not be lifted soon.
  • China is also retaliating against the Phils, Vietnam, Taiwan and changing tack in Europe. The next couple of years threatens to be “interesting times.

CPMC (906 HK): Not A Shadow Of Doubt (!) As Pre-Cons Fulfilled

By David Blennerhassett

  • My conversation with the FA earlier this week largely put to rest a number of concerns, specifically on regulatory approvals, surrounding the Offer for CPMC Holdings (906 HK)
  • As announced on the 13th December, the last pre-condition, SAFE, has been satisfied. All pre-cons have been fulfilled.  The Offer Doc will be dispatched on or before the 20th December
  • This could turn unconditional before year-end, depending on whether Zhang Wei promptly tenders. Expect the share price to trade tight (er) to terms Monday morning.

MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: One Add, One Delete & Other Changes

By Brian Freitas


China Healthcare Weekly (Dec.15) – 10th VBP Results, WuXi Shares Surge, Newjf Will Be Successful

By Xinyao (Criss) Wang

  • The 10th national VBP released results. The average price reduction was about 70%. CSPC, Kelun, Fosun Pharma, Sino Biopharmaceutical are the “main force” and their performance would be affected.
  • WuXi Shares surge due to the absence of BIOSECURE Act from the proposed amendments to US NDAA. However, the rally could be short-term as the Bill may return next year.
  • Pre-Conditions of Newjf have been smooth so far. We think investors can directly consider Newjf’s Offer. Based on the current situation, we are optimistic that Newjf will finally be successful.

Quiddity Leaderboard Hang Seng Internet & IT March 25: 4 Changes Likely, Some Names Have High Impact

By Janaghan Jeyakumar, CFA

  • The Hang Seng Internet & IT (HSIII) index represents the top 30 stocks related to internet and information technology businesses listed in Hong Kong (HKEX).
  • In this insight, we take a look at the rankings of potential ADDs and potential DELs for the March 2025 index rebal event.
  • Based on the latest available data, we see four ADDs and four DELs for HSIII in March 2025.

A Review of Major Equity Indices in Korea in 2024

By Douglas Kim

  • In this insight, we review the major equity indices in Korea in 2024 including KOSPI 200 and Korea Value Up Index. 
  • Some alpha generating performances continue in terms of adding stocks to be included in the KOSPI 200 and reducing stocks that could be excluded.
  • Korea Value Up Index has been heavily promoted by the Korean Exchange this year. Korea Exchange plans to make special changes to the Korea Value-Up Index constituents on 20 December. 

Last Week in Event SPACE: NEC Network, SingPost, Seven & I, CPMC, Exedy

By David Blennerhassett


Quiddity Leaderboard HSCEI Mar 25: One Change Likely but More Names Lurking Close to the Border

By Janaghan Jeyakumar, CFA

  • The HSCEI serves as a benchmark to reflect the overall performance of the top 50 “Mainland China” securities listed in Hong Kong.
  • In this insight, we take a look at the final rankings for the HSCEI potential ADDs and potential DELs for the index rebal event in March 2025.
  • At present, we see one change based on the 13th December 2024 data but the rankings can change until 31st December 2024.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Alibaba Group Holdings: The Tale Of International E-commerce & Cross-border Growth! – Major Drivers and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Alibaba Group Holdings: The Tale Of International E-commerce & Cross-border Growth! – Major Drivers
  • Restaurant Brands International (QSR): Expanding Franchisee Base & Local Ownership Dynamics For Catalyzing Top-Line Growth! – Major Drivers
  • Alphabet’s Big Tech Bets: Quantum, AI, and the Mixed-Reality Fight for Survival!
  • Arcos Dorados Holdings: Will Its Efforts Towards Consumer Engagement & Loyalty Programs Yield Results? – Major Drivers
  • Sinopharm (1099 HK) – A Compelling Investment Case
  • DocuSign Inc.: Leveraging Advanced Document Technologies To Set New Standards! – Major Drivers
  • Cogent Communications Holdings Inc.: An Analysis Of Its Wavelength Services & Network Expansion! – Major Drivers
  • GitLab Inc.: High Adoption & Expansion of GitLab Ultimate Driving Our Optimism! – Major Drivers
  • Foot Locker Inc.: An Analysis Of Its Strategic Brand & Product Collaborations & Other Major Drivers
  • Dollar General Corporation: Can Its Expansion in New Store Formats Give Them A Competitive Edge? – Major Drivers


Alibaba Group Holdings: The Tale Of International E-commerce & Cross-border Growth! – Major Drivers

By Baptista Research

  • Alibaba Group’s September Quarter 2024 results reveal a balance of positive developments and ongoing challenges.
  • The company has shown resilience in its core business segments, leveraging an AI-driven strategy to enhance user engagement and operational efficiency.
  • Steady growth has been noted in both domestic and international e-commerce segments, with Alibaba International Digital Commerce recording a substantial 29% revenue growth.

Restaurant Brands International (QSR): Expanding Franchisee Base & Local Ownership Dynamics For Catalyzing Top-Line Growth! – Major Drivers

By Baptista Research

  • Restaurant Brands International’s (RBI) Q3 2024 earnings show a nuanced performance across its diverse portfolio, which includes brands like Tim Hortons, Burger King, Popeyes, and Firehouse Subs.
  • The company navigated a challenging macroeconomic landscape, yet managed to exhibit both stability and strategic growth in certain areas.
  • The company reported flat comparable sales growth at 0.3%, alongside a net restaurant growth of 3.8%, culminating in a system-wide sales growth of 3.2%.

Alphabet’s Big Tech Bets: Quantum, AI, and the Mixed-Reality Fight for Survival!

By Baptista Research

  • Alphabet Inc., the parent company of Google, has long been a dominant force in the tech world, leveraging its search, cloud, and AI capabilities.
  • Recent announcements, including the development of its custom quantum computing chip “Willow,” the launch of Gemini 2.0 AI models, and its partnership with Samsung for mixed-reality headsets, have spurred investor optimism.
  • These developments come against the backdrop of an earnings call highlighting impressive revenue growth and expanding AI applications across search, cloud services, and autonomous driving.

Arcos Dorados Holdings: Will Its Efforts Towards Consumer Engagement & Loyalty Programs Yield Results? – Major Drivers

By Baptista Research

  • Arcos Dorados Holdings, the world’s largest independent McDonald’s franchisee, reported its third quarter 2024 results showcasing both strengths and challenges.
  • The quarter revealed resilience in Arcos Dorados’ business model with strong sales driven by its digital platforms and off-premise channels such as delivery and drive-thru.
  • However, the company’s performance also faced hurdles due to economic conditions and currency devaluations.

Sinopharm (1099 HK) – A Compelling Investment Case

By Avien Pillay

  • Sinopharm will benefit from the strong expected growth in China’s healthcare spend.
  • There is scope to increase its distribution which will continue to shield the company from short-term volatility.
  • Pricing pressure in drug prices creates opportunity to optimise range and improve profitability.

DocuSign Inc.: Leveraging Advanced Document Technologies To Set New Standards! – Major Drivers

By Baptista Research

  • DocuSign recently reported its third-quarter fiscal 2025 results, reflecting both promising advancements and ongoing challenges.
  • The company delivered an 8% year-over-year growth in revenue, reaching $755 million, driven primarily by improvements in its core business.
  • Subscription revenue mirrored this at $735 million.

Cogent Communications Holdings Inc.: An Analysis Of Its Wavelength Services & Network Expansion! – Major Drivers

By Baptista Research

  • Cogent Communications Holdings reported its third-quarter 2024 financial results marked by efforts to optimize costs and streamline operations following the acquisition of Sprint Global Markets.
  • A substantial achievement of $165 million in cost savings out of a target of $220 million was noted, attributed to synergies between the merged entities.
  • Revenue for the quarter stood at $257.2 million.

GitLab Inc.: High Adoption & Expansion of GitLab Ultimate Driving Our Optimism! – Major Drivers

By Baptista Research

  • GitLab’s recent quarterly results reveal a complex, yet promising landscape for the company.
  • GitLab reported arevenue increase of 31% year-over-year, reaching $196 million for the third quarter of fiscal year 2025.
  • The company exceeded profitability guidance with a non-GAAP operating margin of 13.2%, up more than 1,000 basis points from the prior year.

Foot Locker Inc.: An Analysis Of Its Strategic Brand & Product Collaborations & Other Major Drivers

By Baptista Research

  • Foot Locker’s third-quarter financial performance fell short of the company’s expectations, resulting in a more conservative full-year outlook.
  • The company reported a modest increase in comparable sales of 2.4% for the quarter, driven primarily by gains in Foot Locker and Kids Foot Locker banners, along with a return to positive territory for Champs Sports and WSS banners.
  • However, this progress did not translate as strongly as anticipated into overall sales growth, leading to an adjustment in earnings guidance.

Dollar General Corporation: Can Its Expansion in New Store Formats Give Them A Competitive Edge? – Major Drivers

By Baptista Research

  • Dollar General’s third quarter results for fiscal 2024 present a mixed picture of operational resilience amid challenging external conditions and internal initiatives aimed at enhancing financial and operational metrics.
  • The company’s performance during the quarter was impacted by several hurricanes in the Southeast, which the management noted as significant in terms of employee deployment and store operations, though the overall sales impact was minimal.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: The LLM Quant Revolution: From ChatGPT to Wall Street and more

By | Daily Briefs, Macro

In today’s briefing:

  • The LLM Quant Revolution: From ChatGPT to Wall Street
  • South Korean President Yoon Suk-Yeol Is Impeached by the National Assembly – What’s Next?


The LLM Quant Revolution: From ChatGPT to Wall Street

By William Mann

  • A Comprehensive Guide to Building AI-Powered Investment Systems: The application of Large Language Models (LLMs) in quantitative finance, focusing on the current state of LLM technology in financial applications 
  • I also cover: 1. Comparative analysis of leading models                2. Implementation frameworks for production systems 3. Risk management and quality control considerations 
  • Key Findings: 1. Multi-model approaches outperform single-model solutions 2. Production implementation requires robust quality controls 3. Model selection should be task-specific within the investment process 

South Korean President Yoon Suk-Yeol Is Impeached by the National Assembly – What’s Next?

By Douglas Kim

  • On 14 December, South Korean President Yoon Suk-Yeol was impeached by the National Assembly in a vote of 204 out of 300 seats.
  • The Constitutional Court could take about 90-180 days in making the final decision on the impeachment of President Yoon. 
  • Now that President Yoon has been impeached, Han Duk-Soo (Prime Minister) will become the temporary acting President of South Korea.   

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Vulcan Energy Resources and more

By | Australia, Daily Briefs

In today’s briefing:

  • MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: One Add, One Delete & Other Changes


MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: One Add, One Delete & Other Changes

By Brian Freitas


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Korea Stock Exchange Kospi Index, KB Financial and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Yoon’s Impeachment Passed: Upcoming Schedule, Procedures, and Market Impact
  • A Review of Major Equity Indices in Korea in 2024


Yoon’s Impeachment Passed: Upcoming Schedule, Procedures, and Market Impact

By Sanghyun Park

  • The impeachment motion against President Yoon passed in the South Korean National Assembly, clearing the two-thirds supermajority, and is now official.
  • For the impeachment to fail, four justices must oppose it—highly unlikely given the current setup. The odds are heavily in favor of the impeachment being upheld.
  • Corporate law reforms, driven by a likely Democratic Party takeover, could fuel value-up momentum and drive the local market, potentially sparking an unexpected rally through the May election.

A Review of Major Equity Indices in Korea in 2024

By Douglas Kim

  • In this insight, we review the major equity indices in Korea in 2024 including KOSPI 200 and Korea Value Up Index. 
  • Some alpha generating performances continue in terms of adding stocks to be included in the KOSPI 200 and reducing stocks that could be excluded.
  • Korea Value Up Index has been heavily promoted by the Korean Exchange this year. Korea Exchange plans to make special changes to the Korea Value-Up Index constituents on 20 December. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Alphabet , Brown Forman Corp Class B, Cheniere Energy, Cogent Communications Holdings, Cooper Cos, DocuSign , Dollar General, Foot Locker Inc, Gitlab , Guidewire Software and more

By | Daily Briefs, United States

In today’s briefing:

  • Alphabet’s Big Tech Bets: Quantum, AI, and the Mixed-Reality Fight for Survival!
  • Brown-Forman’s Secret Weapon: How Strategic Cost Management May Boost Profits Amid Inflation! – Major Drivers
  • Cheniere Energy Inc.: These Are The 5 Biggest Challenges In Its Path! – Major Drivers
  • Cogent Communications Holdings Inc.: An Analysis Of Its Wavelength Services & Network Expansion! – Major Drivers
  • The Cooper Companies: Expansion of MyDay Capacity As A Vital Factor Driving Growth! – Major Drivers
  • DocuSign Inc.: Leveraging Advanced Document Technologies To Set New Standards! – Major Drivers
  • Dollar General Corporation: Can Its Expansion in New Store Formats Give Them A Competitive Edge? – Major Drivers
  • Foot Locker Inc.: An Analysis Of Its Strategic Brand & Product Collaborations & Other Major Drivers
  • GitLab Inc.: High Adoption & Expansion of GitLab Ultimate Driving Our Optimism! – Major Drivers
  • Guidewire Software Inc.: These Are The 6 Biggest Factors Impacting Its Performance In 2025 & Beyond! – Major Drivers


Alphabet’s Big Tech Bets: Quantum, AI, and the Mixed-Reality Fight for Survival!

By Baptista Research

  • Alphabet Inc., the parent company of Google, has long been a dominant force in the tech world, leveraging its search, cloud, and AI capabilities.
  • Recent announcements, including the development of its custom quantum computing chip “Willow,” the launch of Gemini 2.0 AI models, and its partnership with Samsung for mixed-reality headsets, have spurred investor optimism.
  • These developments come against the backdrop of an earnings call highlighting impressive revenue growth and expanding AI applications across search, cloud services, and autonomous driving.

Brown-Forman’s Secret Weapon: How Strategic Cost Management May Boost Profits Amid Inflation! – Major Drivers

By Baptista Research

  • Brown-Forman has reported its financial results for the first half of the fiscal year 2025, accompanied by a strategic update on its executive leadership transition.
  • The company’s reported net sales showed a decline of 5%, while organic net sales remained consistent when adjusting for divestitures and foreign exchange impacts.
  • Despite these mixed results, Brown-Forman maintains its fiscal year guidance for organic net sales and operating income growth.

Cheniere Energy Inc.: These Are The 5 Biggest Challenges In Its Path! – Major Drivers

By Baptista Research

  • Cheniere Energy reported its third-quarter 2024 financial results, reflecting solid business performance and opportunities as well as challenges within the liquefied natural gas (LNG) market.
  • The company highlighted key accomplishments, including robust financial metrics, increased guidance for the year, and advancements in their long-term projects.
  • Cheniere generated approximately $1.5 billion in consolidated adjusted EBITDA, with distributable cash flow at around $820 million and net income at approximately $900 million for the third quarter.

Cogent Communications Holdings Inc.: An Analysis Of Its Wavelength Services & Network Expansion! – Major Drivers

By Baptista Research

  • Cogent Communications Holdings reported its third-quarter 2024 financial results marked by efforts to optimize costs and streamline operations following the acquisition of Sprint Global Markets.
  • A substantial achievement of $165 million in cost savings out of a target of $220 million was noted, attributed to synergies between the merged entities.
  • Revenue for the quarter stood at $257.2 million.

The Cooper Companies: Expansion of MyDay Capacity As A Vital Factor Driving Growth! – Major Drivers

By Baptista Research

  • Cooper Companies reported a record revenue year for fiscal 2024, achieving $3.9 billion primarily driven by strong performances from its two main divisions, CooperVision and CooperSurgical.
  • Each division marked record revenues, with CooperVision contributing $676 million in Q4, a 9% increase, largely due to its silicone hydrogel lenses like MyDay, Biofinity, and clariti.
  • The division continues to hold a strong market position, especially in torics, multifocals, and myopia management despite a soft end to the quarter for the contact lens market.

DocuSign Inc.: Leveraging Advanced Document Technologies To Set New Standards! – Major Drivers

By Baptista Research

  • DocuSign recently reported its third-quarter fiscal 2025 results, reflecting both promising advancements and ongoing challenges.
  • The company delivered an 8% year-over-year growth in revenue, reaching $755 million, driven primarily by improvements in its core business.
  • Subscription revenue mirrored this at $735 million.

Dollar General Corporation: Can Its Expansion in New Store Formats Give Them A Competitive Edge? – Major Drivers

By Baptista Research

  • Dollar General’s third quarter results for fiscal 2024 present a mixed picture of operational resilience amid challenging external conditions and internal initiatives aimed at enhancing financial and operational metrics.
  • The company’s performance during the quarter was impacted by several hurricanes in the Southeast, which the management noted as significant in terms of employee deployment and store operations, though the overall sales impact was minimal.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Foot Locker Inc.: An Analysis Of Its Strategic Brand & Product Collaborations & Other Major Drivers

By Baptista Research

  • Foot Locker’s third-quarter financial performance fell short of the company’s expectations, resulting in a more conservative full-year outlook.
  • The company reported a modest increase in comparable sales of 2.4% for the quarter, driven primarily by gains in Foot Locker and Kids Foot Locker banners, along with a return to positive territory for Champs Sports and WSS banners.
  • However, this progress did not translate as strongly as anticipated into overall sales growth, leading to an adjustment in earnings guidance.

GitLab Inc.: High Adoption & Expansion of GitLab Ultimate Driving Our Optimism! – Major Drivers

By Baptista Research

  • GitLab’s recent quarterly results reveal a complex, yet promising landscape for the company.
  • GitLab reported arevenue increase of 31% year-over-year, reaching $196 million for the third quarter of fiscal year 2025.
  • The company exceeded profitability guidance with a non-GAAP operating margin of 13.2%, up more than 1,000 basis points from the prior year.

Guidewire Software Inc.: These Are The 6 Biggest Factors Impacting Its Performance In 2025 & Beyond! – Major Drivers

By Baptista Research

  • Guidewire Software’s recent earnings for the first fiscal quarter of 2025 provides insightful details on the company’s strategic initiatives and financial performance.
  • The company reported a strong start to the fiscal year, emphasizing momentum in cloud adoption and strategic international growth.
  • On the positive side, Guidewire Software demonstrated robust performance with total revenue reaching $263 million, marking a 27% year-over-year increase.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars